Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Gotlib

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2018
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and PerspectivesPeter Valent, Joanna N G Oude Elberink, Aleksandra Gorska, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances|April 9, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREMJohannes Lübke, Alicia Schmid, Deborah Christen, et al.
Allergy|April 23, 2024
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registryMarek Niedoszytko, Aleksandra Gorska, Knut Brockow, et al.
Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Blood Advances|September 12, 2022
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E Kennedy, Cecelia Perkins, Andreas Reiter, et al.
NEJM Evidence|February 6, 2024
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Blood|June 29, 2022
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic dataDaniel A Arber, Attilio Orazi, Robert P Hasserjian, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
The Journal of Allergy and Clinical Immunology. in Practice|November 13, 2018
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and PerspectivesPeter Valent, Joanna N G Oude Elberink, Aleksandra Gorska, et al.
Cancer Medicine|August 18, 2018
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit)Celalettin Ustun, Elizabeth Morgan, Erica E M Moodie, et al.
Blood Advances|April 9, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREMJohannes Lübke, Alicia Schmid, Deborah Christen, et al.
Allergy|April 23, 2024
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registryMarek Niedoszytko, Aleksandra Gorska, Knut Brockow, et al.
Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Blood Advances|May 18, 2021
Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se Young Han, Krzysztof Mrózek, Jenna Voutsinas, et al.
Blood Advances|September 12, 2022
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM RegistryVanessa E Kennedy, Cecelia Perkins, Andreas Reiter, et al.
NEJM Evidence|February 6, 2024
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.
Journal of Hematology & Oncology|June 26, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry studyOlivier Hermine, Orianne Debeaupuis, Gandhi Damaj, et al.
Blood|June 29, 2022
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic dataDaniel A Arber, Attilio Orazi, Robert P Hasserjian, et al.
Pageof 21